Evidence map›Paper›PMID 25697504›Full record

ArticleNucleic acids research2015

Restriction-modification system with methyl-inhibited base excision and abasic-site cleavage activities.

Masaki Fukuyo, Toshiaki Nakano, Yingbiao Zhang, Yoshikazu Furuta, Ken Ishikawa, Miki Watanabe-Matsui, Hirokazu Yano, Takeshi Hamakawa, Hiroshi Ide, Ichizo Kobayashi

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Review
  3. PNAS nexus · 2025
    Article
  4. Base-excision restriction enzymes: expanding the world of epigenetic immune systems.DNA research : an international journal for rapid publication of reports on genes and genomes · 2023
    Article
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Masaki FukuyoDepartment of Medical Genome Sciences, Graduate School of Frontier Sciences, University of Tokyo, Tokyo 108-8639, Japan Institute of Medical Science, University of Tokyo, Minato-ku, Tokyo 108-8639, Japan Department of Evolutionary Studies of Biosystems, School of Advanced Sciences, The Graduate University for Advanced Studies (SOKENDAI), Hayama, Kanagawa 240-0193, Japan Department of Molecular Oncology, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan.
Toshiaki NakanoDepartment of Mathematical and Life Sciences, Graduate School of Science, Hiroshima University Higashi-Hiroshima 739-8526, Japan.
Yingbiao ZhangDepartment of Medical Genome Sciences, Graduate School of Frontier Sciences, University of Tokyo, Tokyo 108-8639, Japan Institute of Medical Science, University of Tokyo, Minato-ku, Tokyo 108-8639, Japan.
Yoshikazu FurutaDepartment of Medical Genome Sciences, Graduate School of Frontier Sciences, University of Tokyo, Tokyo 108-8639, Japan Institute of Medical Science, University of Tokyo, Minato-ku, Tokyo 108-8639, Japan.
Ken IshikawaDepartment of Medical Genome Sciences, Graduate School of Frontier Sciences, University of Tokyo, Tokyo 108-8639, Japan Institute of Medical Science, University of Tokyo, Minato-ku, Tokyo 108-8639, Japan Department of Biophysics and Biochemistry, Graduate School of Science, University of Tokyo, Tokyo 113-8654, Japan.
Miki Watanabe-MatsuiDepartment of Medical Genome Sciences, Graduate School of Frontier Sciences, University of Tokyo, Tokyo 108-8639, Japan Institute of Medical Science, University of Tokyo, Minato-ku, Tokyo 108-8639, Japan.
Hirokazu YanoDepartment of Medical Genome Sciences, Graduate School of Frontier Sciences, University of Tokyo, Tokyo 108-8639, Japan Institute of Medical Science, University of Tokyo, Minato-ku, Tokyo 108-8639, Japan.
Takeshi HamakawaDepartment of Mathematical and Life Sciences, Graduate School of Science, Hiroshima University Higashi-Hiroshima 739-8526, Japan.
Hiroshi IdeDepartment of Mathematical and Life Sciences, Graduate School of Science, Hiroshima University Higashi-Hiroshima 739-8526, Japan.
Ichizo KobayashiDepartment of Medical Genome Sciences, Graduate School of Frontier Sciences, University of Tokyo, Tokyo 108-8639, Japan Institute of Medical Science, University of Tokyo, Minato-ku, Tokyo 108-8639, Japan Department of Biophysics and Biochemistry, Graduate School of Science, University of Tokyo, Tokyo 113-8654, Japan ikobaya@ims.u-tokyo.ac.jp.
The University of Tokyo · JPHiroshima University · JPTokyo University of Science · JPChiba University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The restriction-modification systems use epigenetic modification to distinguish between self and nonself DNA. A modification enzyme transfers a methyl group to a base in a specific DNA sequence while its cognate restriction enzyme introduces breaks in DNA lacking this methyl group. So far, all the restriction enzymes hydrolyze phosphodiester bonds linking the monomer units of DNA. We recently reported that a restriction enzyme (R.PabI) of the PabI superfamily with half-pipe fold has DNA glycosylase activity that excises an adenine base in the recognition sequence (5'-GTAC). We now found a second activity in this enzyme: at the resulting apurinic/apyrimidinic (AP) (abasic) site (5'-GT#C, # = AP), its AP lyase activity generates an atypical strand break. Although the lyase activity is weak and lacks sequence specificity, its covalent DNA-R.PabI reaction intermediates can be trapped by NaBH4 reduction. The base excision is not coupled with the strand breakage and yet causes restriction because the restriction enzyme action can impair transformation ability of unmethylated DNA even in the absence of strand breaks in vitro. The base excision of R.PabI is inhibited by methylation of the target adenine base. These findings expand our understanding of genetic and epigenetic processes linking those in prokaryotes and eukaryotes.

Indexed as

DNA RepairArchaeal ProteinsBase SequenceDNADNA-(Apurinic or Apyrimidinic Site) LyaseDNA DamageDNA GlycosylasesDNA Restriction EnzymesDNA Restriction-Modification EnzymesElectrophoresis, Polyacrylamide GelMethyltransferasesOligonucleotidesPyrococcus abyssiSite-Specific DNA-Methyltransferase (Adenine-Specific)Archaeal ProteinsDNADNA-(Apurinic or Apyrimidinic Site) LyaseDNA GlycosylasesDNA Restriction EnzymesDNA Restriction-Modification EnzymesMethyltransferasesOligonucleotidesSite-Specific DNA-Methyltransferase (Adenine-Specific)

Identifiers

PMID25697504
PMCPMC4357717
OpenAlexW2121686791

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.